Everett Harris & Co. CA Invests $637,000 in Kenvue Inc. $KVUE

Everett Harris & Co. CA acquired a new stake in Kenvue Inc. (NYSE:KVUE) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 33,351 shares of the company’s stock, valued at approximately $637,000.

Other large investors have also made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Kenvue by 25.8% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 410,874 shares of the company’s stock valued at $7,088,000 after buying an additional 84,219 shares during the period. Calamos Advisors LLC boosted its position in Kenvue by 24.1% during the first quarter. Calamos Advisors LLC now owns 3,351,000 shares of the company’s stock worth $57,771,000 after acquiring an additional 651,000 shares during the last quarter. State of Wyoming boosted its position in Kenvue by 233.5% during the fourth quarter. State of Wyoming now owns 97,992 shares of the company’s stock worth $1,690,000 after acquiring an additional 68,609 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its stake in Kenvue by 21.5% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 3,491,548 shares of the company’s stock worth $60,229,000 after acquiring an additional 618,720 shares during the period. Finally, Cullen Frost Bankers Inc. grew its stake in Kenvue by 19.9% in the 4th quarter. Cullen Frost Bankers Inc. now owns 431,394 shares of the company’s stock worth $7,442,000 after acquiring an additional 71,591 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

KVUE has been the topic of a number of recent analyst reports. Barclays increased their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. UBS Group lowered their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Tuesday. Zacks Research lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Finally, Wall Street Zen downgraded Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $19.27.

Kenvue Stock Performance

Shares of KVUE stock opened at $19.20 on Friday. Kenvue Inc. has a one year low of $14.02 and a one year high of $21.84. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01. The company has a 50 day moving average price of $18.95 and a 200 day moving average price of $18.14. The firm has a market capitalization of $36.87 billion, a price-to-earnings ratio of 22.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.47.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). The firm had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The company’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.29 earnings per share. Sell-side analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th will be paid a dividend of $0.21 per share. This is a boost from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.84 annualized dividend and a yield of 4.4%. The ex-dividend date is Wednesday, August 12th. Kenvue’s payout ratio is currently 96.55%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.